| Usha N Peri, MD | |
|
1600 Waters Ridge, Ste A, Lewisville, TX 75057 | |
| (972) 219-0558 | |
| (972) 436-9273 |
| Full Name | Usha N Peri |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 33 Years |
| Location | 1600 Waters Ridge, Lewisville, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033100375 | NPI | - | NPPES |
| 390008039 | Other | RR MEDICARE | |
| 4004203 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | K4527 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renal Center Of Lewisville | Lewisville, TX | Dialysis facility |
| Medical City Lewisville | Lewisville, TX | Hospital |
| Texas Health Presbyterian Hospital Flower Mound | Flower mound, TX | Hospital |
| Baylor Scott And White Medical Center Carrollton | Carrollton, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Texas Kidney Disease Associates | 0941296107 | 23 |
News Archive
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors that trigger asthmatic events have been fairly well characterized and are similar regardless of the asthma-inducing stimuli.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced an innovative collaboration with the American College of Cardiology focused on enhancing clinical research with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). PCSK9 is known to contribute to circulating low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is being co-developed by Sanofi and Regeneron.
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the launch of its newest model addition in the miniature high pressure high flow proportional valve series VSO MAX HP for OEMs looking for innovation in controlling the flow of inert gases.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.
› Verified 7 days ago
| Entity Name | North Texas Kidney Disease Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821169632 PECOS PAC ID: 0941296107 Enrollment ID: O20040422001106 |
News Archive
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors that trigger asthmatic events have been fairly well characterized and are similar regardless of the asthma-inducing stimuli.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced an innovative collaboration with the American College of Cardiology focused on enhancing clinical research with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). PCSK9 is known to contribute to circulating low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is being co-developed by Sanofi and Regeneron.
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the launch of its newest model addition in the miniature high pressure high flow proportional valve series VSO MAX HP for OEMs looking for innovation in controlling the flow of inert gases.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Usha N Peri, MD 3315 Colorado Blvd, Ste A, Denton, TX 76210-6884 Ph: (940) 320-1708 | Usha N Peri, MD 1600 Waters Ridge, Ste A, Lewisville, TX 75057 Ph: (972) 219-0558 |
News Archive
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors that trigger asthmatic events have been fairly well characterized and are similar regardless of the asthma-inducing stimuli.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced an innovative collaboration with the American College of Cardiology focused on enhancing clinical research with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). PCSK9 is known to contribute to circulating low-density lipoprotein cholesterol (LDL-C) levels. Alirocumab is being co-developed by Sanofi and Regeneron.
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the launch of its newest model addition in the miniature high pressure high flow proportional valve series VSO MAX HP for OEMs looking for innovation in controlling the flow of inert gases.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.
› Verified 7 days ago
Shoaib Zafar, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 500 W Main St, Lewisville, TX 75057 Phone: 469-370-2000 | |
Antonio Victor Prudente Gonzalez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 118 Lynn Ave Ste 100, Lewisville, TX 75057 Phone: 214-912-2604 Fax: 804-285-5754 | |
Dr. Dennis James Costa, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2790 Lake Vista Dr, Lewisville, TX 75067 Phone: 972-459-1300 Fax: 972-459-1382 | |
Dr. Syed M Ali, MBBS, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1600 Waters Ridge Dr, Suite A, Lewisville, TX 75057 Phone: 972-219-0558 Fax: 972-436-9273 | |
Bruce Alan Harman, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1165 S. Stemmons Freeway, Suite 108, Lewisville, TX 75067 Phone: 972-434-8000 Fax: 972-434-8001 | |
Megan Toole, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 500 Hutchinson Ln, Lewisville, TX 75077 Phone: 850-590-1736 |